Further evaluation of the relationship between MTFR2 staining and patient clinical characteristics showed that the MTFR2 protein level in BC tissues is associated with age, tumour grade, lymph node metastasis and HER2 status. This evidence concerns the gene ERBB2 and breast cancer.